
Åke Borg
Principal investigator

Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma
Author
Summary, in English
We applied 27k spotted cDNA microarray slides to assess gene expression profiles in 26 samples from 24 patients with synovial sarcomas (SS). The data were analyzed in relation to histopathologic type, cytogenetic aberrations, gene fusion type and development of distant metastases. Supervised analysis based on gene fusion type in 12 SS with SS18/SSXI and 9 with SS18/SSX2 revealed significant differences in gene expression profiles. Among the discriminators were several genes that have previously been found to be upregulated in SS, including AXL, ZIC2, SPAG7, AGRN, FOXC1, NCAM1 and multiple metallothioneins. Histopathology and degree of cytogenetic complexity did not significantly influence expression, whereas a genetic signature that related to development of metastases could be discerned, albeit with a high false-positive rate. In conclusion, our findings demonstrate differentially expressed genes for the 2 major gene fusion variants in SS, SS18/SSX1 and SS18/SSX2, and thereby suggest that these result in different downstream effects. (c) 2005 Wiley-Liss, Inc.
Department/s
- Breastcancer-genetics
- Computational Biology and Biological Physics - Undergoing reorganization
- Division of Clinical Genetics
- Tumor microenvironment
- Orthopaedics (Lund)
Publishing year
2006
Language
English
Pages
1165-1172
Publication/Series
International Journal of Cancer
Volume
118
Issue
5
Document type
Journal article
Publisher
John Wiley & Sons Inc.
Topic
- Cancer and Oncology
Keywords
- gene expression
- synovial sarcoma
- cDNA microarray
- SS18/SSX
Status
Published
ISBN/ISSN/Other
- ISSN: 0020-7136